Total Payments
$9,782
2024 Payments
$2,741
Companies
19
Transactions
614
Medicare Patients
1,898
Medicare Billing
$106,852
Payment Breakdown by Category
Food & Beverage$9,541 (97.5%)
Education$240.99 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,541 | 611 | 97.5% |
| Education | $240.99 | 3 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,202 | 150 | $0 (2024) |
| Janssen Biotech, Inc. | $1,759 | 88 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $750.15 | 116 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $719.53 | 34 | $0 (2024) |
| UCB, Inc. | $658.94 | 44 | $0 (2024) |
| GENZYME CORPORATION | $597.82 | 18 | $0 (2024) |
| PFIZER INC. | $463.61 | 27 | $0 (2024) |
| Amgen Inc. | $459.02 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $456.40 | 20 | $0 (2024) |
| Dermavant Sciences, Inc. | $426.97 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,741 | 178 | ABBVIE INC. ($479.04) |
| 2023 | $2,959 | 183 | Janssen Biotech, Inc. ($638.76) |
| 2022 | $2,032 | 124 | ABBVIE INC. ($623.78) |
| 2021 | $2,050 | 129 | AbbVie Inc. ($549.96) |
All Payment Transactions
614 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.37 | General |
| Category: Immunology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $12.75 | General |
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Immunology | ||||||
| 12/09/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Inflammation & Immunology | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.27 | General |
| Category: Immunology | ||||||
| 12/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Immunology | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.77 | General |
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.73 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.91 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $11.50 | General |
| 10/31/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $1.91 | General |
| 10/31/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $0.74 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.40 | General |
| Category: Immunology | ||||||
| 10/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 486 | 764 | $79,530 | $27,257 |
| 2022 | 8 | 486 | 763 | $78,420 | $27,902 |
| 2021 | 8 | 425 | 612 | $61,328 | $25,548 |
| 2020 | 8 | 501 | 683 | $61,160 | $26,145 |
Total Patients
1,898
Total Services
2,822
Medicare Billing
$106,852
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 272 | $35,360 | $12,499 | 35.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 65 | 91 | $14,560 | $5,668 | 38.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 70 | 99 | $11,880 | $2,753 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $6,150 | $2,240 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 28 | $4,760 | $1,715 | 36.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 21 | 23 | $3,220 | $1,193 | 37.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 42 | 195 | $1,950 | $777.80 | 39.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 15 | $1,650 | $411.95 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 198 | 265 | $34,450 | $12,958 | 37.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 62 | 83 | $13,280 | $5,215 | 39.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 71 | 93 | $11,160 | $2,920 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 47 | $7,990 | $2,850 | 35.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $4,800 | $1,596 | 33.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 24 | 24 | $3,360 | $1,249 | 37.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 44 | 206 | $2,060 | $816.00 | 39.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 12 | $1,320 | $297.54 | 22.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 152 | 193 | $22,420 | $9,619 | 42.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 64 | 83 | $12,220 | $5,517 | 45.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 51 | $7,090 | $3,197 | 45.1% |
| 17000 | Destruction of skin growth | Office | 2021 | 61 | 72 | $8,040 | $2,260 | 28.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 31 | 31 | $4,340 | $1,902 | 43.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $3,250 | $1,380 | 42.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 19 | 21 | $2,800 | $1,084 | 38.7% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 34 | 146 | $1,168 | $588.18 | 50.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 157 | 170 | $22,100 | $10,237 | 46.3% |
About Kyle Horton-Maser
Kyle Horton-Maser is a Nurse Practitioner healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2015. The National Provider Identifier (NPI) number assigned to this provider is 1558754044.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kyle Horton-Maser has received a total of $9,782 in payments from pharmaceutical and medical device companies, with $2,741 received in 2024. These payments were reported across 614 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($9,541).
As a Medicare-enrolled provider, Horton-Maser has provided services to 1,898 Medicare beneficiaries, totaling 2,822 services with total Medicare billing of $106,852. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Williamsville, NY
- Active Since 03/09/2015
- Last Updated 03/09/2015
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558754044
Products in Payments
- TREMFYA (Drug) $1,705
- SKYRIZI (Biological) $1,253
- DUPIXENT (Biological) $838.96
- Sotyktu (Drug) $719.53
- RINVOQ (Biological) $605.33
- Otezla (Drug) $459.02
- VTAMA (Drug) $426.97
- EUCRISA (Drug) $371.44
- OPZELURA (Drug) $330.18
- COSENTYX (Drug) $321.24
- TALTZ (Drug) $317.96
- COSENTYX (Biological) $300.86
- Cimzia (Drug) $288.81
- ADBRY (Biological) $267.33
- Bimzelx (Biological) $250.76
- HUMIRA (Biological) $237.88
- SPEVIGO (Drug) $106.21
- CIBINQO (Drug) $92.17
- LIBTAYO (Biological) $68.69
- REMICADE (Biological) $53.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Williamsville
Susan Kreppel, Np, NP
Nurse Practitioner — Payments: $65,919
Nurse Practitioner $65,919
Julia Gajewski
Nurse Practitioner — Payments: $12,641
Nurse Practitioner $12,641
Jessica Mancuso, Fnp, FNP
Nurse Practitioner — Payments: $6,571
Nurse Practitioner $6,571
Ms. Isabel Molina, Pmhnp-Bc, PMHNP-BC
Nurse Practitioner — Payments: $5,890
Nurse Practitioner $5,890
Lance Guyett, Acnp, ACNP
Nurse Practitioner — Payments: $2,800
Nurse Practitioner $2,800
Susan Wegrzyn, Anp, ANP
Nurse Practitioner — Payments: $1,942
Nurse Practitioner $1,942